WO2013168179A3 - Controlled release pharmaceutical formulations of antiviral agents - Google Patents
Controlled release pharmaceutical formulations of antiviral agents Download PDFInfo
- Publication number
- WO2013168179A3 WO2013168179A3 PCT/IN2013/000219 IN2013000219W WO2013168179A3 WO 2013168179 A3 WO2013168179 A3 WO 2013168179A3 IN 2013000219 W IN2013000219 W IN 2013000219W WO 2013168179 A3 WO2013168179 A3 WO 2013168179A3
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- controlled release
- antiviral agents
- pharmaceutical formulations
- release pharmaceutical
- present
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
- A61K9/0065—Forms with gastric retention, e.g. floating on gastric juice, adhering to gastric mucosa, expanding to prevent passage through the pylorus
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
- A61K31/403—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with carbocyclic rings, e.g. carbazole
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/4965—Non-condensed pyrazines
- A61K31/497—Non-condensed pyrazines containing further heterocyclic rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2022—Organic macromolecular compounds
- A61K9/2027—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
- A61K9/2086—Layered tablets, e.g. bilayer tablets; Tablets of the type inert core-active coat
Landscapes
- Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Epidemiology (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Nutrition Science (AREA)
- Physiology (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
Abstract
The present invention relates to controlled release formulation of direct acting antiviral agents, and to processes for preparation of the same. The present invention provides controlled release formulation comprising direct acting antiviral agents, at least one release modifier and at least one pharmaceutically acceptable excipient.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
IN1090MU2012 | 2012-04-03 | ||
IN1090/MUM/2012 | 2012-04-03 |
Publications (2)
Publication Number | Publication Date |
---|---|
WO2013168179A2 WO2013168179A2 (en) | 2013-11-14 |
WO2013168179A3 true WO2013168179A3 (en) | 2014-01-30 |
Family
ID=49551414
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/IN2013/000219 WO2013168179A2 (en) | 2012-04-03 | 2013-04-03 | Controlled release pharmaceutical formulations of antiviral agents |
Country Status (1)
Country | Link |
---|---|
WO (1) | WO2013168179A2 (en) |
Families Citing this family (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN111107843B (en) * | 2017-06-30 | 2024-01-09 | 财团法人工业技术研究院 | Use of compounds for preparing medicine for treating autoimmune nerve disease and/or neurodegenerative disease, and liquid and controlled release pharmaceutical preparations thereof |
Citations (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1608621A (en) * | 2003-10-23 | 2005-04-27 | 中国医学科学院药物研究所 | Fine bicyclic alcohol powder and oral bicyclic alcohol release controlling prepn |
CN101237858A (en) * | 2005-07-19 | 2008-08-06 | 爱的发 | Gastroretentive formulations and manufacturing process thereof |
CN101495095A (en) * | 2006-04-28 | 2009-07-29 | 先灵公司 | Process for the precipitation and isolation of 6,6-dimethyl-3-aza-bicyclo [3.1.0] hexane-amide compounds by controlled precipitation andpharmaceutical formulations containing same |
WO2010093843A2 (en) * | 2009-02-12 | 2010-08-19 | Vertex Pharmaceuticals Incorporated | Hcv combination therapies |
CN101820887A (en) * | 2007-07-25 | 2010-09-01 | 拜奥雷克斯治疗公司 | Controlled release interferon drug products and treatment of hcv infection using sam |
-
2013
- 2013-04-03 WO PCT/IN2013/000219 patent/WO2013168179A2/en active Application Filing
Patent Citations (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1608621A (en) * | 2003-10-23 | 2005-04-27 | 中国医学科学院药物研究所 | Fine bicyclic alcohol powder and oral bicyclic alcohol release controlling prepn |
CN101237858A (en) * | 2005-07-19 | 2008-08-06 | 爱的发 | Gastroretentive formulations and manufacturing process thereof |
CN101495095A (en) * | 2006-04-28 | 2009-07-29 | 先灵公司 | Process for the precipitation and isolation of 6,6-dimethyl-3-aza-bicyclo [3.1.0] hexane-amide compounds by controlled precipitation andpharmaceutical formulations containing same |
CN101820887A (en) * | 2007-07-25 | 2010-09-01 | 拜奥雷克斯治疗公司 | Controlled release interferon drug products and treatment of hcv infection using sam |
WO2010093843A2 (en) * | 2009-02-12 | 2010-08-19 | Vertex Pharmaceuticals Incorporated | Hcv combination therapies |
Also Published As
Publication number | Publication date |
---|---|
WO2013168179A2 (en) | 2013-11-14 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
WO2012021715A3 (en) | Stable formulations of linaclotide | |
PH12016501122A1 (en) | Delayed release compositions of linaclotide | |
PH12015500274B1 (en) | Alkylpyrimidine derivatives for the treatment of viral infections and further diseases | |
WO2015018380A3 (en) | Therapeutic nanoparticles and the preparation methods thereof | |
WO2013134534A3 (en) | Solid state forms of cabazitaxel and processes for preparation thereof | |
IN2014MN02236A (en) | ||
TN2012000488A1 (en) | Pharmaceutical compositions comprising hydromorphone and naloxone | |
TN2015000135A1 (en) | Modified release formulations for oprozomib | |
WO2013171764A3 (en) | Ophthalmic formulations | |
WO2012101653A3 (en) | Modified release pharmaceutical compositions memantine | |
WO2014100351A3 (en) | 8'-hydroxy-dihydroergotamine compounds and compositions | |
WO2014033526A9 (en) | Pharmaceutical compositions of etoricoxib | |
MX2015005762A (en) | Co-micronisation product comprising ulipristal acetate. | |
BR112017009510A2 (en) | compositions comprising cyclosporine | |
WO2012087255A3 (en) | Pharmaceutical formulations comprising imatinib | |
WO2016197042A8 (en) | Modified or targeted release formulations of linaclotide | |
WO2014159501A3 (en) | Processes for preparing tetrahydroisoquinolines | |
WO2013168179A3 (en) | Controlled release pharmaceutical formulations of antiviral agents | |
EP2409685A3 (en) | Orally-disintegrating formulations of prasugrel | |
WO2014122671A3 (en) | Solid oral compositions of saxagliptin | |
WO2011139255A3 (en) | Pharmaceutical compositions comprising cefetamet | |
WO2014055941A8 (en) | Compounds and methods for targeted immune system delivery | |
WO2013115736A3 (en) | Bilayer tablet formulations of flurbiprofen and glucosamin | |
WO2013124832A3 (en) | Stabilized controlled-release pharmaceutical composition comprising gliclazide | |
WO2013093458A3 (en) | Antiviral compounds |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
122 | Ep: pct application non-entry in european phase |
Ref document number: 13787956 Country of ref document: EP Kind code of ref document: A2 |